• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.

作者信息

Richardson A, Bayliss J, Scriven A J, Parameshwar J, Poole-Wilson P A, Sutton G C

机构信息

Hillingdon Hospital, Uxbridge, Middlesex.

出版信息

Lancet. 1987 Sep 26;2(8561):709-11. doi: 10.1016/s0140-6736(87)91074-9.

DOI:10.1016/s0140-6736(87)91074-9
PMID:2888942
Abstract

Captopril alone as therapy for mild heart failure was compared with a combination of frusemide and amiloride in a double-blind randomised crossover trial in 14 patients who had previously been treated with diuretics. Although 10 patients remained stable on captopril alone, 4 patients deteriorated, with the development of pulmonary oedema of breathlessness. All 4 patients had had pulmonary oedema previously, unlike the patients who remained stable. Angiotensin converting enzyme inhibition alone is not sufficient treatment for patients with mild heart failure and a history of overt pulmonary oedema.

摘要

相似文献

1
Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure.
Lancet. 1987 Sep 26;2(8561):709-11. doi: 10.1016/s0140-6736(87)91074-9.
2
Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.心力衰竭患者的症状评估:中等程度心力衰竭中递增剂量利尿剂与卡托普利的双盲比较
Lancet. 1986 Oct 4;2(8510):770-2. doi: 10.1016/s0140-6736(86)90298-9.
3
Addition of captopril versus increasing diuretics in moderate but deteriorating heart failure: a double-blind comparative trial.卡托普利与增加利尿剂剂量治疗中度但病情恶化心力衰竭的比较:一项双盲对照试验。
Postgrad Med J. 1986;62 Suppl 1:184-7.
4
Double-blind, randomised, cross-over comparison of oral captopril and enoximone added to diuretic treatment in patients with severe heart failure.口服卡托普利与依诺昔酮添加到利尿剂治疗重度心力衰竭患者的双盲、随机、交叉对照研究
J Cardiovasc Pharmacol. 1988 Jan;11(1):45-50. doi: 10.1097/00005344-198801000-00007.
5
The renin angiotensin aldosterone system and frusemide response in congestive heart failure.充血性心力衰竭中的肾素-血管紧张素-醛固酮系统与速尿反应
Br J Clin Pharmacol. 1995 Jan;39(1):51-7. doi: 10.1111/j.1365-2125.1995.tb04409.x.
6
A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
J Int Med Res. 1988 Mar-Apr;16(2):143-9. doi: 10.1177/030006058801600209.
7
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.对接受血管紧张素转换酶抑制剂治疗的慢性心力衰竭患者停用洋地黄。RADIANCE研究。
N Engl J Med. 1993 Jul 1;329(1):1-7. doi: 10.1056/NEJM199307013290101.
8
Effect of isosorbide-5-mononitrate on exercise performance and clinical status in patients with congestive heart failure. Results of the Nitrates in Congestive Heart Failure (NICE) Study.5-单硝酸异山梨酯对充血性心力衰竭患者运动能力和临床状况的影响。充血性心力衰竭硝酸盐类药物(NICE)研究结果。
Cardiology. 1999;91(1):1-7. doi: 10.1159/000006870.
9
An open, randomized comparative study of a low-strength frusemide/amiloride combination and bumetanide/potassium chloride in the treatment of mild congestive cardiac failure.低强度速尿/阿米洛利组合与布美他尼/氯化钾治疗轻度充血性心力衰竭的开放性随机对照研究
J Int Med Res. 1990;18 Suppl 2:10B-16B.
10
A double-blind, cross-over comparison of the effects of a loop diuretic and a dopamine receptor agonist as first line therapy in patients with mild congestive heart failure.
Eur Heart J. 1997 May;18(5):852-7. doi: 10.1093/oxfordjournals.eurheartj.a015351.

引用本文的文献

1
Diuretic use in the adult Fontan.成人Fontan手术患者中利尿剂的使用
Int J Cardiol Congenit Heart Dis. 2022 Apr 28;8:100387. doi: 10.1016/j.ijcchd.2022.100387. eCollection 2022 Jun.
2
Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions - Part I: Loop Diuretics.心力衰竭患者的利尿剂治疗:当前证据和未来方向 - 第一部分:袢利尿剂。
Curr Heart Fail Rep. 2024 Apr;21(2):101-114. doi: 10.1007/s11897-024-00643-3. Epub 2024 Jan 19.
3
Pathophysiology and Management of Heart Failure in the Elderly.老年人心力衰竭的病理生理学与管理
Int J Angiol. 2022 Nov 11;31(4):251-259. doi: 10.1055/s-0042-1758357. eCollection 2022 Dec.
4
To Curb the Progression of Fatal COVID-19 Course-Dream or Reality.遏制致命 COVID-19 病程进展——梦想还是现实。
Curr Hypertens Rep. 2021 Feb 27;23(2):12. doi: 10.1007/s11906-021-01130-z.
5
Fluid Management in Patients with Chronic Heart Failure.慢性心力衰竭患者的液体管理
Card Fail Rev. 2015 Oct;1(2):90-95. doi: 10.15420/cfr.2015.1.2.90.
6
Heart failure: chapter 8. Treatment of end-stage heart failure.心力衰竭:第8章。终末期心力衰竭的治疗。
Neth Heart J. 2004 Dec;12(12):548-554.
7
Recombinant adeno-associated virus utilizes cell-specific infectious entry mechanisms.重组腺相关病毒利用细胞特异性感染进入机制。
J Virol. 2014 Nov;88(21):12472-84. doi: 10.1128/JVI.01971-14. Epub 2014 Aug 20.
8
Congestion is the driving force behind heart failure.充血是心力衰竭背后的驱动力。
Curr Heart Fail Rep. 2012 Sep;9(3):219-27. doi: 10.1007/s11897-012-0093-9.
9
Key role of congestion in natural history of heart failure.充血在心力衰竭自然病程中的关键作用。
Int J Gen Med. 2011;4:585-91. doi: 10.2147/IJGM.S24108. Epub 2011 Aug 15.
10
Diuretics as pathogenetic treatment for heart failure.利尿剂治疗心力衰竭的病理生理学机制。
Int J Gen Med. 2011 Jan 23;4:91-8. doi: 10.2147/IJGM.S16635.